
Sign up to save your podcasts
Or
Biotechnology and pharmaceutical companies are increasingly investing in the development for therapeutics for hearing disorders. In this episode, Dr. Brian Taylor sits down with Celia Belline, CEO of CILCare and Peter Markham, CEO of CBSET, to discuss the future of pharmaceuticals and regenerative medicine in the identification and treatment of hearing disorders.
Be sure to subscribe to our YouTube channel for the latest episodes each week, and follow This Week in Hearing on LinkedIn and Twitter:
https://www.linkedin.com/company/this-week-in-hearing/
https://twitter.com/WeekinHearing
5
11 ratings
Biotechnology and pharmaceutical companies are increasingly investing in the development for therapeutics for hearing disorders. In this episode, Dr. Brian Taylor sits down with Celia Belline, CEO of CILCare and Peter Markham, CEO of CBSET, to discuss the future of pharmaceuticals and regenerative medicine in the identification and treatment of hearing disorders.
Be sure to subscribe to our YouTube channel for the latest episodes each week, and follow This Week in Hearing on LinkedIn and Twitter:
https://www.linkedin.com/company/this-week-in-hearing/
https://twitter.com/WeekinHearing
9,140 Listeners
111,827 Listeners
9,555 Listeners
6,751 Listeners
2 Listeners
16 Listeners
15,237 Listeners
10,521 Listeners